Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
Items 301–400 of 1,016
Natural killer cell–mediated inflammation resolution is disabled in severe asthma
Duvall, M. G., Barnig, C., Cernadas, M., Ricklefs, I., Krishnamoorthy, N., Grossman, N. L., Bhakta, N. R., Fahy, J. V., Bleecker, E. R., Castro, M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam5446 · Cited by 114
“The glucocorticoid potency of dexamethasone is about five times that of an equivalent dose of triamcinolone, and the concentration of dexamethasone used in vitro may have been more immunosuppressive than the in vivo dose of triamcinolone (25).”
BackgroundThe Effective Analgesic Dose of Dexamethasone After Laparoscopic Hysterectomy
Jokela, R. M., Ahonen, J. V., Tallgren, M. K., Marjakangas, P. C., & Korttila, K. T. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181ac0f5c · Cited by 118
Maneechotesuwan, K., Yao, X., Ito, K., Jazrawi, E., Usmani, O. S., Adcock, I. M., & Barnes, P. J. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000076 · Cited by 107
“Alternatively, activated GR interacts with coactivator molecules to suppress the expression of inflammatory genes by inhibiting the action of proinflammatory transcription factors such as nuclear factor-kB (NF-kB) through the recruitment of co-repressor molecules such as histone deacetylase-2 [17,18].”
BackgroundCorticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-Analysis
Nie, W., Zhang, Y., Cheng, J.-W., & Xiu, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047926 · Cited by 108
“They can switch on genes that encode antiinflammatory cytokines and switch off genes that encode proinflammatory cytokines [27,28].”
BackgroundSpies, C. M., Strehl, C., van der Goes, M. C., Bijlsma, J. W. J., & Buttgereit, F. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.11.002 · Cited by 113
European Guideline ( EuroGuiDerm ) on atopic eczema: Living update
Wollenberg, A., Kinberger, M., Arents, B. W. M., ASZODI, N., Barbarot, S., Bieber, T. R. M., Brough, H. A., Calzavara‐Pinton, P., Christen‐Zaech, S., Deleuran, M. S., et al. (2025) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20639 · Cited by 127
“32 There are only a few studies in adult and paediatric AE patients, despite the regular use of systemic glucocorticoste-roids in clinical practice.”
Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate
Comstock, T. L., & DeCory, H. H. (2012) · International Journal of Inflammation · doi:10.1155/2012/789623 · Cited by 117
“However, recent work suggests that the activated corticosteroid-GR complex also elicits nongenomic effects, particularly the inhibition of vasodilation, vascular permeability, and migration of leukocytes [7, 9].”
BackgroundPierce, H., Zhang, D., Magnon, C., Lucas, D., Christin, J. R., Huggins, M., Schwartz, G. J., & Frenette, P. S. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.01.002 · Cited by 100
“GCs inhibit the immune response through various mechanisms, including nuclear factor kB (NF-kB) inhibition, Annexin I stimulation, and MAPK phosphatase stimulation, that are at the nexus of critical pro-inflammatory pathways (Rhen and Cidlowski, 2005).”
BackgroundThe history of endocrine-disrupting chemicals
Darbre, P. D. (2019) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2019.06.007 · Cited by 126
Sehgal, A., Mehta, S., Sahay, K., Martynova, E. V., Rizvanov, A. A., Baranwal, M., Chandy, S., Khaiboullina, S. F., Kabwe, E., & Davidyuk, Y. N. (2023) · Viruses · doi:10.3390/v15020561 · Cited by 122
Prins, J., Olivier, B., & Korte, S. M. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.594039 · Cited by 97
“GCs are part of the feedback mechanism in the immune system as well [39].”
BackgroundTang, W., Zhao, Z., Chong, Y., Wu, C., Liu, Q., Yang, J., Zhou, R., Lian, Z., & Liang, G. (2018) · ACS Nano · doi:10.1021/acsnano.8b04143 · Cited by 107
Ishihara, T., Kubota, T., Choi, T., & Higaki, M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.150276 · Cited by 110
“Glucocorticoids can be highly effective in treating joint inflammation, but their systemic application is limited because of a high incidence of serious adverse effects, particularly in long-term treatment (Saag, 2002; Rhen and Cidlowski, 2005).”
BackgroundBarczyk, K., Ehrchen, J., Tenbrock, K., Ahlmann, M., Kneidl, J., Viemann, D., & Roth, J. (2010) · Blood · doi:10.1182/blood-2009-10-247106 · Cited by 105
Exogenous and endogenous glucocorticoids in rheumatic diseases
Buttgereit, F., Burmester, G., Straub, R. H., Seibel, M. J., & Zhou, H. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30070 · Cited by 105
Hue, C. D., Cho, F. S., Cao, S., Bass, C. R., Meaney, D. F., & Morrison, B. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.38 · Cited by 114
Keshri, G. K., Gupta, A., Yadav, A., Sharma, S. K., & Singh, S. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166705 · Cited by 105
Corticosteroid Treatment in Chronic Rhinosinusitis: The Possibilities and the Limits
Mullol, J., Obando, A., Pujols, L., & Alobid, I. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.07.001 · Cited by 105
Management of the Immune Reconstitution Inflammatory Syndrome
Meintjes, G., Scriven, J. E., & Marais, S. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0129-5 · Cited by 120
“element, indirect genomic effects via interference with other transcriptional factors such as nuclear factor-κB and activator protein 1, and nongenomic effects on anti-inflammatory proteins [14, 15].”
BackgroundLi, H., Xie, W., Strong, J. A., & Zhang, J. (2007) · Anesthesiology · doi:10.1097/01.anes.0000278907.37774.8d · Cited by 112
“These mechanisms are thought to have different dose–response curves.(30) Hence, it is likely that understanding the conflicting results about effects of glucocorticoids in nerve injury models will require careful consideration of both dose–response and anatomical site of action of the drugs.”
BackgroundMoran, J. L., Graham, P. L., Rockliff, S., & Bersten, A. D. (2010) · Critical Care · doi:10.1186/cc9182 · Cited by 110
“How then are we to understand these favourable effects of low-dose corticosteroids? Glucocorticoid action on inflammation [57], vascular reactivity [58] and interactions between corticosteroids and ‘signalling pathways’ [59] may explain the salutary effects in sepsis [60]; anti-inflammatory and coagulation effects wou…”
BackgroundGlucocorticoid-induced diabetes and adrenal suppression: How to detect and manage them
Lansang, M. C., & Hustak, L. K. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10180 · Cited by 105
Wolf, D., Anto-Michel, N., Blankenbach, H., Wiedemann, A., Buscher, K., Hohmann, J. D., Lim, B., Bäuml, M., Márki, A., Mauler, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02896-8 · Cited by 109
Biologic therapies for inflammatory eye disease
Lim, L., Suhler, E., & Smith, J. (2006) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01225.x · Cited by 108
Chibli, L. A., Rodrigues, K. C. M., Gasparetto, C. M., Pinto, N. D. C. C., Fabri, R. L., Scio, E., Alves, M. S., Del-Vechio-Vieira, G., & de Sousa, O. V. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.03.035 · Cited by 118
Emerging roles of pulmonary macrophages in driving the development of severe asthma
Yang, M., Kumar, R. K., Hansbro, P. M., & Foster, P. S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0711357 · Cited by 113
“, annexin-1, secretory leukoprotease inhibitor 1, and IL10) [3, 35].”
BackgroundSidibeh, C. O., Pereira, M. J., Abalo, X. M., J. Boersma, G., Skrtic, S., Lundkvist, P., Katsogiannos, P., Hausch, F., Castillejo-López, C., & Eriksson, J. W. (2018) · Endocrine · doi:10.1007/s12020-018-1674-5 · Cited by 104
Bouras, M., Asehnoune, K., & Roquilly, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02590 · Cited by 108
“These numerous effects results from the pleiotropic activity of the glucocorticoid receptor (GR) on multiple gene promotors and on multiple target cells (94).”
BackgroundInfluentialHydrogel-based ocular drug delivery systems for hydrophobic drugs
Torres-Luna, C., Fan, X., Domszy, R. C., Hu, N., Wang, N. S., & Yang, A. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105503 · Cited by 111
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer
Abduljabbar, R. F., Negm, O. H., Lai, C., Jerjees, D. A., Al-kaabi, M. M., Hamed, M. R., Tighe, P. J., Buluwela, L., Mukherjee, A., Green, A. R., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3335-1 · Cited by 111
“The receptor is ubiquitously expressed in many tissues and is essential in the regulation of development, metabolism, immune and anti-inflammatory responses [9, 10].”
BackgroundFeng, X., Wang, D., Chen, J., Lü, L., Hua, B., Li, X., Tsao, B. P., & Sun, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051982 · Cited by 102
“cytokine synthesis, T-cell function, and Fc receptor expression, thereby controlling inflammation and resolving lupus activity [30,31].”
BackgroundPharmacologic Characteristics of Corticosteroids
Samuel, S., Nguyen, T., & Choi, H. A. (2017) · Journal of Neurocritical Care · doi:10.18700/jnc.170035 · Cited by 118
Hardy, R. S., Filer, A., Cooper, M. S., Parsonage, G., Raza, K., Hardie, D. L., Rabbitt, E. H., Stewart, P. M., Buckley, C. D., & Hewison, M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1993 · Cited by 98
“Introduction The profound effects of glucocorticoids on the immune system have underpinned their widespread use as therapeutic agents for inflammatory diseases [1].”
Review article: appropriate use of corticosteroids in Crohn’s disease
Irving, P. M., Gearry, R. B., Sparrow, M., & GIBSON, P. R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03379.x · Cited by 119
Mazet, R., Yaméogo, J. B. G., Wouessidjewe, D., Choisnard, L., & Gèze, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060570 · Cited by 99
“production of all proinflammatory mediators, including the arachidonic acid cited above [1,35,41].”
BackgroundA Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19
Ko, J. J., Wu, C., Mehta, N., Wald‐Dickler, N., Yang, W., & Qiao, R. (2021) · Journal of Intensive Care Medicine · doi:10.1177/0885066621994057 · Cited by 105
“Studies have shown difference of various steroids in their anti-inflammatory biology, beside potency and duration.(8) Corticosteroids can alter the inflammatory pathway at the genomic or through the more rapid-onset non-genomic pathways.”
BackgroundInfluentialRole of PPAR, LXR, and PXR in epidermal homeostasis and inflammation
Schmuth, M., Moosbrugger-Martinz, V., Blunder, S., & Dubrac, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.012 · Cited by 100
Phospholipase A2 subclasses in acute respiratory distress syndrome
Kitsiouli, E., Nakos, G., & Lekka, M. E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.007 · Cited by 110
You, S. Y., Jwa, H. J., Yang, E. A., Kil, H. R., & Lee, J. H. (2013) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2014.6.1.22 · Cited by 110
“Steroids can exert immune regulatory and anti-inflammatory effects through several molecular mechanisms, such as inhibition of nuclear factor κB, and also influence natural lung immunity by regulating alveolar macrophages and neutrophils.(19,20) In our study, all children showed serious clinical features upon admissio…”
BackgroundDiamonds are forever: the cortisone legacy
Hillier, S. G. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0309 · Cited by 100
“…pre-receptor metabolism, glucocorticoid action involves both positive and negative regulation of gene expression with extensive crosstalk between GR and membrane-associated receptors for proinflammatory cytokines, such as interleukin-1 (IL-1) and tumour necrosis factor a (Rhen & Cidlowski 2005).”
BackgroundComprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies
Kim, H. J., & Kim, Y. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168776 · Cited by 116
“They bind to glucocorticoid receptors, regulating gene expression and reducing pro-inflammatory cytokine production [132–138].”
BackgroundMonocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease
Lameijer, M. A., Tang, J., Nahrendorf, M., Beelen, R. H. J., & Mulder, W. J. M. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.819216 · Cited by 97
Yang, C.-Y., Chen, C., Yiang, G., Cheng, Y., Yong, S., Wu, M., & Li, C.-J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020588 · Cited by 100
“The corticosteroids inhibited general inflammation by decreasing the production of prostaglandin via activation of annexin I, which is an anti-inflammatory protein that inhibits cytosolic phospholipase A2a to block the production of arachidonic acid [113,114].”
BackgroundJamaati, H., Hashemian, S. M. R., Farzanegan, B., Malekmohammad, M., Tabarsi, P., Marjani, M., Moniri, A., Abtahian, Z., Haseli, S., Mortaz, E., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173947 · Cited by 97
“After inhibition of NF-κB signaling, glucocorticoids induce inhibition of synthesis of downstream proteins such as IL-1, IL-6, granulocyte-macrophage colony-stimulating factor, and inducible cyclooxygenase-2 (Masjedi et al., 2017; Rhen and Cidlowski, 2005).”
Management of Neuropathic Pain with Methylprednisolone at the Site of Nerve Injury
Eker, H. E., Çok, O. Y., Ariboğan, A., & Arslan, G. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01323.x · Cited by 109
McWhinney, B. C., Briscoe, S., Ungerer, J. P. J., & Pretorius, C. J. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.08.044 · Cited by 105
Options for perioperative pain management in neurosurgery
Vadivelu, N., Kai, A., Tran, D., Kodumudi, G., Legler, A., & Ayrian, E. (2016) · Journal of Pain Research · doi:10.2147/jpr.s85782 · Cited by 97
“39 Also, corticosteroids may relieve headaches postoperatively by decreasing chemical meningitis triggered by the formation of the dust from bone surgically.”
BackgroundChastain, D. B., Spradlin, M., Ahmad, H., & Henao‐Martínez, A. F. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad474 · Cited by 106
Bosscher, K. D., Craenenbroeck, K. V., Meijer, O. C., & Haegeman, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.076 · Cited by 109
Gruver-Yates, A., Quinn, M. A., & Cidlowski, J. A. (2013) · Endocrinology · doi:10.1210/en.2013-1473 · Cited by 102
“Both natural and synthetic glucocorticoids are well known for their immunosuppressive effects, and therefore, glucocorticoids are widely prescribed in clinical settings, including autoimmunity, inflammation, sepsis, and lymphatic cancer (1).”
BackgroundSelf-citationFattori, V., Borghi, S. M., Guazelli, C. F. S., Giroldo, A. C., Crespigio, J., Bussmann, A. J. C., Coelho-Silva, L., Ludwig, N. G., Mazzuco, T. L., Casagrande, R., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.039 · Cited by 119
Molitoris, J. K., McColl, K. S., Swerdlow, S., Matsuyama, M., Lam, M., Finkel, T. H., Matsuyama, S., & Distelhorst, C. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.245423 · Cited by 96
Natural Products in Medicine: Transformational Outcome of Synthetic Chemistry
Szychowski, J., Truchon, J., & Bennani, Y. L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500941m · Cited by 105
Fiacchini, G., Tricò, D., Ribechini, A., Forfori, F., Brogi, E., Lucchi, M., Berrettini, S., Bertini, P., Guarracino, F., & Bruschini, L. (2020) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2020.4148 · Cited by 96
“3 to 10) Heart rate, mean (SD), bpm 91 (22) 80 (14) 10 (1 to 19) Overall burden of comorbiditiesb”
BackgroundThe Role of Dendritic Cells in Tissue-Specific Autoimmunity
Mbongue, J. C., Nicholas, D., Firek, A. F., & Langridge, W. H. R. (2014) · Journal of Immunology Research · doi:10.1155/2014/857143 · Cited by 103
Pan, Q., Xu, Q., Boylan, N. J., Lamb, N. W., G. Emmert, D., Yang, J.-C., Tang, L., Heflin, T., Alwadani, S., Eberhart, C. G., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.009 · Cited by 94
Low-dose hydrocortisone during severe sepsis: Effects on microalbuminuria
Rinaldi, S., Adembri, C., Grechi, S., & Gaudio, A. R. D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000233872.04706.bb · Cited by 96
“Although the role of glucocorticoids during sepsis is still controversial, it is well established that glucocorticoids dosedependently modulate the stress response to sepsis by means of protection from an overshooting inflammatory response, influencing the balance between inflammation and anti-inflammation (13, 14).”
BackgroundMethodAirway remodeling and lack of bronchodilator response in steroid-resistant asthma
Goleva, E., Hauk, P. J., Boguniewicz, J., Martin, R. J., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.042 · Cited by 96
Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite–derived phospholipase
Jarrett, R., Salio, M., Lloyd-Lavery, A., Subramaniam, S., Bourgeois, E., Archer, C., Cheung, K. L., Hardman, C., Chandler, D., Salimi, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6833 · Cited by 92
“It is of interest that corticosteroids 337 are known to inhibit PLA (79), and it may be that in the skin, this is an important mechanism for 338”
Kim, Y., Amidfar, M., & Won, E. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.008 · Cited by 102
Role of the RNA-Binding Protein Tristetraprolin in Glucocorticoid-Mediated Gene Regulation
Ishmael, F. T., Fang, X., Galdiero, M. R., Atasoy, U., Rigby, W. F. C., Gorospe, M., Cheadle, C., & Stellato, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8342 · Cited by 96
“G lucocorticoids (GCs) 3 are potent anti-inflammatory steroids that are used in treatment of the majority of inflammatory diseases (1, 2).”
BackgroundHow to manage patients with corticosteroids in oncology in the era of immunotherapy?
Aldea, M. D., Orillard, É., Mansi, L., Marabelle, A., Scotté, F., Lambotte, O., & Michot, J. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.032 · Cited by 102
“) or other active fungal or parasitic infection [1].”
BackgroundInfluentialImmunosuppressive peptides and their therapeutic applications
Thell, K., Hellinger, R., Schabbauer, G., & Gruber, C. W. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.002 · Cited by 94
Bhattacharyya, S., Zhao, Y., Kay, T. W. H., & Muglia, L. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017296108 · Cited by 93
“Activation of NF-κB and MAPKs is proximal to TLR ligation and accounts for the transcription and stabilization of several inflammatory signatures that function via secondary mediators, such as STATs, for the further progression or resolution of inflammation.”
BackgroundInfluentialTowards an Effective and Safe Treatment of Inflammatory Pain: A Delphi-Guided Expert Consensus
Varrassi, G., Alon, E., Bagnasco, M., Lanata, L., Mayoral, V., Paladini, A., Pergolizzi, J. V., Perrot, S., Scarpignato, C., & Tölle, T. R. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01053-x · Cited by 98
Pukale, S. S., Sharma, S., Dalela, M., Singh, A. K., Mohanty, S., Mittal, A., & Chitkara, D. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.08.020 · Cited by 94
Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia
Nafae, R. M., Ragab, M. I., Amany, F. M., & Rashed, S. B. (2013) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2013.03.009 · Cited by 93
The Roles of Lysosomes in Inflammation and Autoimmune Diseases
Ge, W., Li, D., Gao, Y., & Cao, X. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.936587 · Cited by 104
“Both pathways ultimately act on the arachidonic acid metabolic pathways, leading to reduced expression of PLA-2 and COX-2, thus decreasing prostaglandin (PG) secretion and suppressing inflammation [5].”
BackgroundFeline Gastrointestinal Eosinophilic Sclerosing Fibroplasia
Craig, L. E., Hardam, E. E., Hertzke, D. M., Flatland, B., Rohrbach, B. W., & Moore, R. R. (2008) · Veterinary Pathology · doi:10.1354/vp.46-1-63 · Cited by 93
FKBP51 – a selective modulator of glucocorticoid and androgen sensitivity
Stechschulte, L. A., & Sanchez, E. R. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.012 · Cited by 92
“Glucocorticoid resistance Glucocorticoids are potent and pleiotropic hormones [42] that induce diverse down-regulatory mechanisms to protect against over-stimulation [43].”
BackgroundPostoperative Nausea and Vomiting in Pediatric Patients
Kovac, A. L. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00424-0 · Cited by 106
Choline attenuates immune inflammation and suppresses oxidative stress in patients with asthma
Mehta, A. K., Singh, B., Arora, N., & Gaur, S. N. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.09.004 · Cited by 98
Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages
Chinenov, Y., Coppo, M., Gupte, R., Sacta, M. A., & Rogatsky, I. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-656 · Cited by 90
“These potent anti-inflammatory properties made glucocorticoids exceedingly common for managing a wide range of autoimmune and inflammatory conditions such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, psoriasis and multiple sclerosis [2].”
BackgroundPapi, A. A., Contoli, M., Adcock, I. M., Bellettato, C. M., Padovani, A., Casolari, P., Stanciu, L. A., Barnes, P. J., Johnston, S. L., Ito, K., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.028 · Cited by 92
Glucocorticoids, Inflammation and Bone
Güler-Yüksel, M., Hoes, J. N., Bultink, I. E. M., & Lems, W. F. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0335-7 · Cited by 100
King, E. M., Chivers, J. E., Rider, C. F., Minnich, A., Giembycz, M. A., & Newton, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053936 · Cited by 102
“been thought to explain repression of inflammatory gene expression [1,4].”
BackgroundJing, Y., Li, A., Liu, Z., Yang, P., Wei, J., Chen, X., Zhao, T., Bai, Y., Zha, L., & Zhang, C. (2018) · BioMed Research International · doi:10.1155/2018/1781036 · Cited by 95
“IBD commonly affects young people as a chronic disorder [1] and is conventionally treated with aminosalicylic acids [10, 11], corticosteroids [12], immune suppressants [13, 14], antibiotics [15], and biologic agents [16].”
BackgroundMurugan, S., Jakka, P., Namani, S., Mujumdar, V., & Radhakrishnan, G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005543 · Cited by 91
“Subsequently, these receptors translocate to the nucleus to negatively regulate genes associated with the secretion of inflammatory cytokines (14).”
BackgroundQuatrini, L., Vacca, P., Tumino, N., Besi, F., Pace, A. L. D., Scordamaglia, F., Martini, S., Munari, E., Mingari, M. C., Ugolini, S., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.044 · Cited by 99
Adjunctive therapies for community-acquired pneumonia: a systematic review
Siempos, I. Ι., Vardakas, K. Z., Kopterides, P., & Falagas, M. E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn283 · Cited by 357
Hickman, R. J., Khambaty, T., & Stewart, J. C. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9510-0 · Cited by 90
“This, in turn, could result in increased inflammation, given that glucocorticoids have anti-inflammatory properties (Rhen & Cidlowski, 2005).”
BackgroundMolitoris, J. K., McColl, K. S., & Distelhorst, C. W. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0402 · Cited by 89
“Glucocorticoid hormones play an important role in the development and maintenance of the immune system (1).”
BackgroundMorris, G., Berk, M., Maes, M., Carvalho, A. F., & Puri, B. K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1498-1 · Cited by 85
Immunosuppressive Drug TherapyPreprint
Hartono, C., Muthukumar, T., & Suthanthiran, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015487 · Cited by 90
Role of Inflammation in Depression: Implications for Phenomenology, Pathophysiology and Treatment
Raison, C. L., & Miller, A. H. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343966 · Cited by 88
Anti-inflammatory glucocorticoid drugs: reflections after 60 years
Whitehouse, M. W. (2010) · Inflammopharmacology · doi:10.1007/s10787-010-0056-2 · Cited by 104
“At least four different mechanisms can be distinguished (Goulding 1998; Buttgereit et al. 2005; Rhen and Cidlowski 2005; Barnes 2006; Kirwan and Power 2007; de Bosscher and Haegeman 2009; Spies et al. 2010).”
BackgroundMarkel, T. A., Lou, D., Pfefferkorn, M. D., Scherer, L. R., West, K. W., Rouse, T. M., Engum, S. A., Ladd, A. P., Rescorla, F. J., & Billmire, D. F. (2008) · Surgery · doi:10.1016/j.surg.2008.07.005 · Cited by 91
“wound contraction and poor wound tensile strength.(16) It is, therefore, logical to expect that steroids might affect postoperative rates of wound infections in pediatric patients with ulcerative colitis; however, results from studies on the adult patient population with ulcerative colitis cannot be applied directly t…”
BackgroundResultvan Aalst, M. P., Langedijk, A. C., Spijker, R., de Bree, G. J., Grobusch, M. P., & Goorhuis, A. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.039 · Cited by 91
Mellibovsky, L., Prieto‐Alhambra, D., Mellibovsky, F., Güerri‐Fernández, R., Nogués, X., Randall, C. J., Hansma, P. K., & Díez‐Pérez, A. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2497 · Cited by 92
“Glucocorticoid treatment is widely used and effective for treating a number of immune and inflammatory disorders,((1)) but it can have deleterious effects on the bone.”
BackgroundWu, J., Mackie, S. L., & Pujades‐Rodríguez, M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001220 · Cited by 93
Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model
Matsuo, Y., Ishihara, T., Ishizaki, J., Miyamoto, K., Higaki, M., & Yamashita, N. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.07.004 · Cited by 88
Neurological autoimmunity targeting aquaporin-4
Hinson, S. R., McKeon, A. B., & Lennon, V. A. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.032 · Cited by 92
“They reduce the inflamma- ory response via multiple mechanisms, including downegulation of T and B lymphocytes, monocytes and granlocytes and reduction of cytokine synthesis and secretion Rhen and Cidlowski, 2005).”
Background2018 recommendations for the management of community acquired pneumonia
Corrêa, R. D. A., Costa, A. N., Lundgren, F. L. C., Michelin, L., de Figueiredo, M. R. F., Holanda, M. A., Gomes, M., Teixeira, P. J. Z., Martins, R. L. D. M., Silva, R., et al. (2018) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37562018000000130 · Cited by 119
“Activation of the hypothalamicpituitary-adrenal axis is responsible for the production of cortisol, an endogenous corticosteroid, which, during an pneumonic course, induces the expression of anti-inflammatory proteins and the inhibition of pro-inflammatory molecules.(101)”
BackgroundClaeys, E., & Vermeire, K. (2019) · Journal of Immunological Sciences · doi:10.29245/2578-3009/2019/4.1178 · Cited by 96
Immune regulation of the gut-brain axis and lung-brain axis involved in ischemic stroke
Xie, X., Wang, L., Dong, S., Ge, S., & Zhu, T. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.380869 · Cited by 94
“Furthermore, endogenous glucocorticoids stimulate anti-infectious immunity (Rhen and Cidlowski, 2005).”
Glucocorticosteroids Modify Langerhans Cells To Produce TGF-β and Expand Regulatory T Cells
Stary, G., Klein, I., Bauer, W. M., Koszik, F., Reininger, B., Kohlhofer, S., Gruber, K., Skvara, H., Jung, T., & Stingl, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002485 · Cited by 92
“GCSs are small lipophilic compounds that mediate their biological effects by binding to an intracellular receptor that translocates to the nucleus and targets specific DNA sequences resulting in the blockage of several inflammatory pathways (3, 4) and in the induction of apoptosis (5).”
BackgroundLee, H., Chung, B., Kim, K. S., Seo, K. Y., Choi, B. J., & Kim, T. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.08.015 · Cited by 85
Hewitt, M., Enoch, S. J., Madden, J. C., Przybylak, K. R., & Cronin, M. T. D. (2013) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.811215 · Cited by 85
Bruscoli, S., Donato, V., Velardi, E., Sante, M. D., Migliorati, G., Donato, R., & Riccardi, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070136 · Cited by 88
He, Y., Xu, Y., Zhang, C., Gao, X., Dykema, K. J., Martin, K. R., Ke, J., Hudson, E. A., Khoo, S. K., Resau, J. H., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001450 · Cited by 83
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.